The Personalization of Clopidogrel Antiplatelet Therapy: The Role of Integrative Pharmacogenetics and Pharmacometabolomics

QR Code

The Personalization of Clopidogrel Antiplatelet Therapy: The Role of Integrative Pharmacogenetics and Pharmacometabolomics

Dual antiplatelet therapy of aspirin and clopidogrel is pivotal for patients undergoing percutaneous coronary intervention. However, the variable platelets reactivity response to clopidogrel may lead to outcome failure and recurrence of cardiovascular events. Although many genetic and nongenetic f...

Full description

Bibliographic Details
Main Authors:	Amin, Arwa M., Lim, Sheau Chin, Mohamed Noor, Dzul Azri, SK Abdul Kader, Muhamad Ali, Yuen, Kah Hay, Ibrahim, Baharudin
Format:	Article
Language:	English
Published:	Hindawi Publishing Corporation 2017
Subjects:	RS1-441 Pharmacy and materia medica
Online Access:	http://eprints.usm.my/37261/ http://eprints.usm.my/37261/1/%28The_Personalization_of_Clopidogrel_Antiplatelet%29_8062796.pdf

Similar Items

The Personalization of Clopidogrel Antiplatelet Therapy in Coronary Artery Disease Patients using Pharmacometabonomics, Pharmacogenetics and Platelets Function Testing
by: Mostafa, Arwa Mohamed Amin
Published: (2016)

Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial
by: Bath, Philip M.W., et al.
Published: (2018)

A randomised controlled trial of triple antiplatelet therapy (Aspirin, Clopidogrel and Dipyridamole) in the secondary prevention of stroke: safety, tolerability and feasibility
by: Sprigg, Nikola, et al.
Published: (2008)

Current state and novel approaches of antiplatelet therapy
by: Metharom, P., et al.
Published: (2015)

Antiplatelet therapy following ischaemic stroke: continue or change pre-existing therapy?
by: Mazlan-Kepli, Wardati, et al.
Published: (2017)

Pipeline pharmacogenetics: A novel approach to integrating pharmacogenetics into drug development
by: Akkari, Patrick, et al.
Published: (2009)

Pretreatment with dual antiplatelet therapy in patients with ST-elevation myocardial infarction.
by: Yudi, M., et al.
Published: (2017)

Pharmacogenomics and pharmacometabolomics of selective serotonin reuptake inhibitors in patients with depression at hospitals in the Klang Valley, Malaysia
by: Badamasi, Ibrahim Mohammed
Published: (2019)

Pharmacogenetics, pharmacogenomics and airway disease
by: Hall, Ian P.
Published: (2002)

A Clinical And Pharmacogenetic Investigation Of Methadone Maintenance Therapy (MMT) In Opiate Dependent Individuals
by: Mohamad, Nasir
Published: (2011)

Asthma and Metabolic Syndrome - Where is the Link?
by: Ibrahim, Baharudin, et al.
Published: (2016)

Dual antiplatelet therapy unmasks distinct platelet reactivity in patients with coronary artery disease
by: Peace, A., et al.
Published: (2008)

Early time course of major bleeding on antiplatelet therapy after TIA or ischemic stroke
by: Hilkens, Nina A., et al.
Published: (2018)

A pharmacogenetics study on acute pain perception among patents on methadone maintenance therapy (MMT)
by: Zahari, Zalina
Published: (2016)

A Study On Cyp2c19 Genetic Variations Of Clopidogrel And Ticagrelor Treatment Among Coronary Artery Disease (CAD) Patients Undergoing Percutaneous Coronary Intervention (PCI)
by: Ak-Kaif, Mohammed Ahmed Imran
Published: (2023)

The prevalence of co-administration of clopidogrel and proton pump inhibitors
by: Shrestha, Kajal, et al.
Published: (2011)

Antiplatelet activity should be measured routinely: no
by: Bath, Philip M.W.
Published: (2009)

Interruption to antiplatelet therapy early after acute ischaemic stroke: a nested case-control study
by: Mazlan-Kepli, Wardati, et al.
Published: (2017)

Pharmacogenetics in cardiovascular disorders: An update on the principal drugs
by: Predazzi, I., et al.
Published: (2013)

Pharmacogenetics of beta adrenergic blockers: their clinical significance
by: Elsayed, Tarek Mohamed Ali
Published: (2009)

Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke
by: Sacco, Ralph L., et al.
Published: (2008)

Mechanism of action of antiplatelet drugs on decompression sickness in rats: A protective effect of anti-GPIIbIIIa therapy
by: Lambrechts, K., et al.
Published: (2015)

Phenotypic and pharmacogenetic evaluation of patients with thiazide-induced hyponatremia
by: Ware, James S., et al.
Published: (2017)

Effect of antiplatelet and/or anticoagulation medication on the risk of tympanic barotrauma in hyperbaric oxygen therapy patients and development of a predictive model.
by: Buzzacott, Peter, et al.
Published: (2020)

Antiplatelet therapy for secondary prevention in patients with ischaemic stroke and transient ischaemic attack: a retrospective cohort study in Malaysia
by: Ab Rahman N,, et al.
Published: (2023)

Predicting major bleeding in patients with noncardioembolic stroke on antiplatelets
by: Hilkens, Nina A., et al.
Published: (2017)

Nuclear magnetic resonance spectroscopy based metabolomics to identify novel biomarkers of alcohol-dependence
by: Mostafa, Hamza, et al.
Published: (2017)

Safety and efficacy of intensive vs. guideline antiplatelet therapy in high-risk patients with recent ischemic stroke or transient ischemic attack: rationale and design of the Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke (TARDIS) trial (ISRCTN47823388)
by: Beridze, M., et al.
Published: (2015)

Pretreatment with Dual Antiplatelet Therapy in Patients with Non-ST-Segment Elevation Acute Coronary Syndromes undergoing Percutaneous Coronary Intervention
by: Yudi, M., et al.
Published: (2015)

Medicinal herbals with antiplatelet properties benefit in coronary atherothrombotic diseases
by: Mohd Nor, Nurul Huda, et al.
Published: (2016)

Clopidogrel, Prasugrel or Ticagrelor in Patients with Acute Coronary Syndromes undergoing Percutaneous Coronary Intervention.
by: Yudi, M., et al.
Published: (2016)

Metabolomics and pharmacogenetics based 5-fluorouracil monitoring in colorectal cancer patients
by: Zakaria, Bannur, et al.
Published: (2014)

Metabolomics and pharmacogenetics based 5-fluorouracil monitoring in colorectal cancer patients
by: Bannur, Zakaria, et al.
Published: (2014)

Effect Of Food-drug Interaction On Oral Drug Bioavailability
by: Lim , Sheau Chin
Published: (2006)

Impact of Discontinuation of Antiplatelet Therapy Prior to Isolated Valve and Combined Coronary Artery Bypass Graft and Valve Procedures on Short and Intermediate Term Outcomes
by: Meneguzzi, J., et al.
Published: (2017)

The role of pharmacogenetic variation in metoprolol CYP2D6 genotypes polymorphism
by: Wan Sulaiman, Wan Mohd. Azizi, et al.
Published: (2011)

Can population differences in chemotherapy outcomes be inferred from differences in pharmacogenetic frequencies
by: Loh, M., et al.
Published: (2013)

Genetic polymorphisms and drug interactions leading to clopidogrel resistance: why the Asian population requires special attention
by: Hasan, Md. Shariful, et al.
Published: (2013)

Anti-inflammatory and antiplatelet activities of plasma are conserved across twelve mammalian species
by: Ahmed, Sagheer, et al.
Published: (2014)

Utility of pharmacogenetic testing to optimise antidepressant pharmacotherapy in youth: a narrative literature review
by: Roberts, B., et al.
Published: (2023)